Comparative study of early effects of epipodophyllotoxin derivatives and other cytostatic agents on mastocytoma cultures.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001761:Bleomycin / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects / Q000528:radiation effects; D002460:Cell Line; D003078:Colchicine / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D004273:DNA, Neoplasm / Q000096:biosynthesis; D005047:Etoposide / Q000494:pharmacology*; D012515:Mast-Cell Sarcoma / Q000188:drug therapy* / Q000378:metabolism; D008466:Mechlorethamine / Q000494:pharmacology; D015122:Mercaptopurine / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D008938:Mitosis / Q000187:drug effects; D009363:Neoplasm Proteins / Q000096:biosynthesis; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D012334:RNA, Neoplasm / Q000096:biosynthesis; D011929:Razoxane / Q000494:pharmacology; D013713:Teniposide / Q000494:pharmacology*; D014750:Vincristine / Q000494:pharmacology; D014965:X-Rays
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D003561:Cytarabine; D001761:Bleomycin; D008466:Mechlorethamine; D011929:Razoxane; D014750:Vincristine; D005047:Etoposide; D013713:Teniposide; D015122:Mercaptopurine; D011034:Podophyllotoxin; D003078:Colchicine; D008727:Methotrexate